Meet the Experts

In her role as Principal, Medical Communications, she helps to support her clients in the development of compelling and strategic stories through various medical communications projects. Spanning a variety of therapeutic areas, these activities support the education, training and engagement needs of cross-functional teams at Canadian and US pharmaceutical companies.

Prior to joining, Kwamaa trained microbiologist, and supported exciting research in molecular microbiology and infectious disease. She holds a MSc in Molecular Genetics from the University of Toronto,

As a lover of live music and with a growing green thumb, Kwamaa can be found at various music events or tending to her growing plant collection.

Thought Leadership

Medical Affairs
- Case Study: Establishing the Scientific Stories of Novel Gene Therapies
  Learn how we guided our client through early-stage clinical trials and competitive pressures to craft a compelling scientific narrative. Read the case study.
- Case Study: Enhancing Manuscripts for Top-Tier Journal Publication
  We helped a clinical-stage genetic medicine company enhance their manuscript and figures to meet the high standards of a top scientific journal. Discover how our targeted narrative refinement and figure enhancement led to their research being featured in a prestigious journal with an impact factor of 4.6.
- Case Study: Development of a Scientific Platform for Biotech Client
  Our biotech client was facing the challenge of introducing a new competitor into the market while simultaneously gaining a deeper understanding of their disease state. To navigate this complex scenario, they needed a strategic document that would serve as the foundation for both internal and external communications.
- Case Study: KOL Identification and Engagement Planning in Rare Disease Clinical Development
  Our client, a leading biopharmaceutical company, sought to embark on a clinical development program within a new therapeutic area in the rare disease space. Read the case study.
- Article: Unveiling Insights: How KOLs Shaped a Groundbreaking Therapy’s Journey
  A recent pivotal Phase 3 clinical trial marked a significant milestone for our client, a biopharmaceutical company, in their quest to introduce a novel treatment for major depressive disorder (MDD). Read more.